Journal Club - Empagliflozin to Improve Heart Failure Symptoms Dr. Nandita Mohan5 May 2022 4:30 PM ISTPatients hospitalized for acute heart failure (AHF) experience poor health status, including high burden of symptoms and physical limitations, and...
Empagliflozin rapidly improves symptoms and QoL in Hospitalised AHF Patients: EMPULSE Trial Medha Baranwal18 April 2022 9:45 AM ISTUSA: Treatment with empagliflozin in patients hospitalized for acute heart failure (AHF) produces clinical benefits and improves the quality of life,...
Early initiation of Empagliflozin Improves QoL in Acute HF Patients within 2 weeks: EMPULSE Trial MD Bureau9 April 2022 10:30 AM ISTIntroduction Patients hospitalized for acute heart failure (AHF) are at high risk for cardiovascular death and readmission, and also experience an...
Empagliflozin improves cognitive impairment in frail diabetics with HFpEF: Study Medha Baranwal1 April 2022 10:45 AM ISTItaly: SGLT2 inhibitor empagliflozin improves cognitive and physical impairment in frail older adults with type 2 diabetes and heart failure with...
Combo of empagliflozin plus MRA safe in HFpEF patients, may reduce hyperkalemia risk: JACC Medha Baranwal26 March 2022 10:30 AM ISTDelhi: A recent study has found that treatment with empagliflozin improves clinical outcomes in patients with heart failure with preserved ejection...
2/March/2022 Top Medical Bulletin Dr. Nandita Mohan2 March 2022 5:54 PM ISTHere are top medical stories for todayNon–Vitamin K Antagonist Oral Anticoagulants helpful in Stroke A recent study published in JAMA...
Eli Lilly, Boehringer Ingelheim gets USFDA nod for Jardiance to treat heart failure regardless of ejection fraction MD Bureau26 Feb 2022 11:00 AM ISTIndianapolis: Eli Lilly and Company and Boehringer Ingelheim have recently announced that the U.S. Food and Drug Administration (USFDA) has...
FDA approves Jardiance for heart failure in adults Dr. Kamal Kant Kohli25 Feb 2022 1:54 AM ISTThe U.S. Food and Drug Administration has approved diabetes drug Jardiance for heart failure in adults. This will help reduce the risk of...
Emperor preserved trial: Empagliflozin effective to treat heart failure Dr. Nandita Mohan10 Feb 2022 7:30 PM IST The EMPEROR-Preserved trial reports empagliflozin is superior to placebo in improving heart failure outcomes among patients with symptomatic...
SGLT2 inhibitor empagliflozin may improve brain's insulin sensitivity in prediabetics: Study Medha Baranwal28 Dec 2021 10:00 AM ISTGermany: Researchers in a recent study published in Diabetes Care have shown for the first time that the SGLT2 inhibitor empagliflozin can be used for...
Empagliflozin retains benefits in 'True' HFpEF Patients Ruchika Sharma3 Dec 2021 5:31 PM ISTEmpagliflozin provides a wide range of benefits in patients with "true" heart failure and preserved ejection fraction (HFpEF) , meaning an LVEF of 50%...
Empagliflozin safe in acute HF, improves 'Clinical Benefit' over time Dr. Nandita Mohan2 Dec 2021 10:42 AM ISTPatients with acute heart failure were safely started on empagliflozin a median of 3 days after hospitalization and were 36% more likely to...
